Arcus Biosciences

$38.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.36 (+3.67%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RCUS and other stocks, options, and ETFs commission-free!

About RCUS

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA. The listed name for RCUS is Arcus Biosciences, Inc.

CEO

Terry J. Rosen

Employees

139

Headquarters

Hayward, California

Founded

2015

Market Cap

2.60B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

584.82K

High Today

$38.87

Low Today

$36.53

Open Price

$36.61

Volume

388.48K

52 Week High

$40.01

52 Week Low

$8.55

Collections

Analyst Ratings

91%

of 11 ratings

Buy

91%

Hold

Sell

RCUS Earnings

-$0.93

-$0.60

-$0.28

$0.05

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, After Hours